Sentence examples for trial for risk from inspiring English sources
Two reviewers (JL and JK or JW) independently assessed each trial for risk of bias utilising the risk of bias tool developed by the Cochrane Collaboration [ 9].
We assessed the included trials for risk of bias as described in the method section (Table 3).
They can be used in randomised controlled trials for risk stratification and to increase power in adjusted analyses [ 2], and for risk adjustment in non-randomised comparisons [ 3].
Two review authors (SvN, SH) independently assessed a selection of trials for risk of bias and reached consensus on the final results.
This study demonstrated the feasibility of using archival FFPE cell blocks from FNAs to establish RNA-based molecular signatures unique to pancreatic adenocarcinoma with potential applications in clinical trials for risk stratification, patient selection, and target validation.
We will use the Cochrane risk of bias tool to assess non-randomised controlled trials for risks of performance, detection, attrition and reporting biases.
A judgement was made about each trial for each risk of bias domain assessed.
This was a randomised, phase III clinical trial for high risk, oestrogen receptor (ER) negative/ER weakly positive early breast cancer.
This study utilized a cross-sectional design, using baseline data gathered between 2009 and 2012 as part of a longitudinal randomized controlled trial for reducing risk behaviors among HIV-infected alcohol abusers.
To overcome the limitations described above, we started an IMRT trial for high risk prostate cancer with a target volume definition based on the average distribution of positive lymph nodes in prostate cancer patients complemented by sentinel node functional imaging with SPECT.
This study was designed to characterize the incidence of new clinically detectable neurologic events, or any comparative change in indices of higher cognitive function following transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) within the framework of a prospective, randomized clinical trial for high-risk patients.
